Claire Doshier Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2026 Last refreshed 2026-05-16

faculty

3 h-index 59 pubs 20 cited

Biography and Research Information

OverviewAI-generated summary

Claire Doshier's research investigates the molecular mechanisms underlying cancer, with a recent focus on identifying therapeutic targets in lymphoma. Her work has explored the role of NEK2 as a regulator of oncogenic pathways in lymphoma, as indicated by her 2023 publication "Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma." Doshier also has research interests in cellular senescence and regeneration, as demonstrated in her 2024 publication "Damage-Induced Senescent Immune Cells Regulate Regeneration of the Zebrafish Retina." Her scholarship metrics include an h-index of 3, 59 total publications, and 19 total citations.

Metrics

  • h-index: 3
  • Publications: 59
  • Citations: 20

Selected Publications

  • Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma (2023)
    13 citations DOI OpenAlex

View all publications on OpenAlex →

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics